Skip to main content

Table 4 Survival statistics for the two treatment cohorts [median (95% CI)]

From: Analysis of the efficacy of upfront brain radiotherapy versus deferred radiotherapy for EGFR/ALK-positive non-small cell lung cancer with brain metastases: a retrospective study

 

Upfront RT

Deferred RT

Log-rank

P

iPFS

26.90(20.38,33.42)

20.20(15.15.25.25)

5.408

0.020

OS

31.20(22.24,40.16)

22.30(18.96,25.64)

4.667

0.031

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us